Literature DB >> 2465997

Astrocytes regulate GFAP mRNA levels by cyclic AMP and protein kinase C-dependent mechanisms.

B Shafit-Zagardo1, A Kume-Iwaki, J E Goldman.   

Abstract

Glial fibrillary acidic protein (GFAP) mRNA and protein levels in rat astrocyte cultures and in the human astrocytoma line U-373MG were examined in order to determine the effects of agents that regulate cAMP-dependent kinase and protein kinase C. Treatment of cells with dibutyryl cAMP or forskolin and 3-isobutyl-1-methylxanthine increased steady-state GFAP mRNA levels. Short-term treatment of cells with phorbol-12-myristate-13-acetate (PMA) increased GFAP mRNA levels, but prolonged treatment of cells with PMA or 1-oleoyl-2-acetyl-rac-glycerol produced a dramatic decrease in GFAP mRNA; 4-beta-phorbol had no effect. Thus, both cAMP-dependent kinase and protein kinase C may exert regulatory roles in determining GFAP mRNA levels. Nuclear run-off studies showed no change in GFAP mRNA synthesis after cAMP or PMA treatment, suggesting post-transcriptional mechanisms. Western blot analysis revealed that the effect of PMA on U-373MG cells shows specificity in that GFA protein levels decline, while those of other major cytoskeletal proteins were unaltered.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2465997     DOI: 10.1002/glia.440010507

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  17 in total

Review 1.  Quantitative aspects of reactive gliosis: a review.

Authors:  W T Norton; D A Aquino; I Hozumi; F C Chiu; C F Brosnan
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

Review 2.  Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects.

Authors:  Soheila Karimi-Abdolrezaee; Rohini Billakanti
Journal:  Mol Neurobiol       Date:  2012-06-09       Impact factor: 5.590

3.  Astrocyte-specific heme oxygenase-1 hyperexpression attenuates heme-mediated oxidative injury.

Authors:  Luna Benvenisti-Zarom; Raymond F Regan
Journal:  Neurobiol Dis       Date:  2007-03-24       Impact factor: 5.996

4.  Blockade of Neuroglobin Reduces Protection of Conditioned Medium from Human Mesenchymal Stem Cells in Human Astrocyte Model (T98G) Under a Scratch Assay.

Authors:  Eliana Baez-Jurado; Gina Guio Vega; Gjumrakch Aliev; Vadim V Tarasov; Paula Esquinas; Valentina Echeverria; George E Barreto
Journal:  Mol Neurobiol       Date:  2017-03-22       Impact factor: 5.590

5.  Genomic structure of human microtubule-associated protein 2 (MAP-2) and characterization of additional MAP-2 isoforms.

Authors:  N Kalcheva; J Albala; K O'Guin; H Rubino; C Garner; B Shafit-Zagardo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

6.  Glial-specific cAMP response of the glial fibrillary acidic protein gene cell lines.

Authors:  R Kaneko; N Hagiwara; K Leader; N Sueoka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Products of cells from gliomas: IX. Evidence that two fundamentally different mechanisms change extracellular matrix expression by gliomas.

Authors:  P E McKeever; J Varani; S M Papadopoulos; M Wang; J P McCoy
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

8.  Protein kinase C isoform alpha overexpression in C6 glioma cells and its role in cell proliferation.

Authors:  G H Baltuch; N P Dooley; K M Rostworowski; J G Villemure; V W Yong
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

9.  p-Chlorophenylalanine, a serotonin synthesis inhibitor, reduces the response of glial fibrillary acidic protein induced by trauma to the spinal cord. An immunohistochemical investigation in the rat.

Authors:  H S Sharma; Y Olsson; J Cervós-Navarro
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury.

Authors:  Julia E Herrmann; Tetsuya Imura; Bingbing Song; Jingwei Qi; Yan Ao; Thu K Nguyen; Rose A Korsak; Kiyoshi Takeda; Shizuo Akira; Michael V Sofroniew
Journal:  J Neurosci       Date:  2008-07-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.